{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:59:25Z","timestamp":1777078765632,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T00:00:00Z","timestamp":1492387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00277-017-2958-1","type":"journal-article","created":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T06:46:30Z","timestamp":1492411590000},"page":"951-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Impact of cachexia on outcomes in aggressive lymphomas"],"prefix":"10.1007","volume":"96","author":[{"given":"Reem","family":"Karmali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Alrifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtihaj A. M.","family":"Fughhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineela","family":"Chukkapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palmi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjib","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Szymanski-Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo I.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parameswaran","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Penedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,17]]},"reference":[{"issue":"5","key":"2958_CR1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V83.5.1165.1165","volume":"83","author":"MA Shipp","year":"1994","unstructured":"Shipp MA (1994) Prognostic factors in aggressive non-Hodgkin\u2019s lymphoma: who has \u201chigh-risk\u201d disease? Blood 83(5):1165\u20131173","journal-title":"Blood"},{"issue":"6","key":"2958_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J et al (2008) Cachexia: a new definition. Clin Nutr 27(6):793\u2013799","journal-title":"Clin Nutr"},{"issue":"10","key":"2958_CR3","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1200\/JCO.1995.13.10.2600","volume":"13","author":"AJ Staal-van den Brekel","year":"1995","unstructured":"Staal-van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF (1995) Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13(10):2600\u20132605","journal-title":"J Clin Oncol"},{"issue":"1","key":"2958_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urology.2006.09.039","volume":"69","author":"K Kuroda","year":"2007","unstructured":"Kuroda K, Nakashima J, Kanao K et al (2007) Interleukin 6 is associated with cachexia in patients with prostate cancer. Urology 69(1):113\u2013117","journal-title":"Urology"},{"key":"2958_CR5","doi-asserted-by":"publisher","unstructured":"Demetrius LA, Coy JF, Tuszynski JA. (2010) Cancer proliferation and therapy: the Warburg effect and quantum metabolism. Theor Biol Med Model. 7:2. doi: 10.1186\/1742-4682-7-2","DOI":"10.1186\/1742-4682-7-2"},{"issue":"6","key":"2958_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0261-5614(90)90004-C","volume":"9","author":"EW Fredrix","year":"1990","unstructured":"Fredrix EW, Soeters PB, Wouters EF, Deerenberg IM, von Meyenfeldt MF, Saris WH (1990) Energy balance in relation to cancer cachexia. Clin Nutr 9(6):319\u2013324","journal-title":"Clin Nutr"},{"issue":"5","key":"2958_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF (2016) Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev 30(5):489\u2013501","journal-title":"Genes Dev"},{"issue":"4","key":"2958_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","volume":"219","author":"JS Falconer","year":"1994","unstructured":"Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC (1994) Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219(4):325\u2013331","journal-title":"Ann Surg"},{"key":"2958_CR9","unstructured":"Ohnuma T. 2003 Manifestations of Cachexia. Holland-Frei Cancer Medicine. Hamilton"},{"key":"2958_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"Project TIN-HsLPF","year":"1993","unstructured":"Project TIN-HsLPF (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The international non-Hodgkin\u2019s lymphoma prognostic factors project. N Engl J Med 329:987\u2013994","journal-title":"N Engl J Med"},{"issue":"3","key":"2958_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/bjh.12763","volume":"165","author":"AM Perry","year":"2014","unstructured":"Perry AM, Alvarado-Bernal Y, Laurini JA et al (2014) MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab. Br J Haematol 165(3):382\u2013391","journal-title":"Br J Haematol"},{"issue":"22","key":"2958_CR12","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS et al (2008) Lymphoma\/leukemia molecular profiling project. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359(22):2313\u20132323","journal-title":"N Engl J Med"},{"issue":"7","key":"2958_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3109\/10428191003802365","volume":"51","author":"S Uddin","year":"2010","unstructured":"Uddin S, Bu R, Ahmed M, Hussain AR, Ajarim D, Al-Dayel F et al (2010) Leptin receptor expression and its association with PI3K\/AKT signaling pathway in diffuse large B-cell lymphoma. Leukemia & Lymphoma 51(7):1305\u20131314","journal-title":"Leukemia & Lymphoma"},{"issue":"8","key":"2958_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00277-014-2116-y","volume":"93","author":"A Carbone","year":"2014","unstructured":"Carbone A, Gloghini A, Kwong Y-L, Younes A (2014) Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy. Ann Hematol 93(8):1263\u20131277","journal-title":"Ann Hematol"},{"key":"2958_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4137\/CMO.S30891","volume":"9","author":"SH Jafri","year":"2015","unstructured":"Jafri SH, Previgliano C, Khandelwal K, Shi R (2015) Cachexia index in advanced non-small-cell lung cancer patients. Clin Med Insights Oncol 9:87\u201393","journal-title":"Clin Med Insights Oncol"},{"key":"2958_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275\u2013282","journal-title":"Blood"},{"key":"2958_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3945\/ajcn.113.060228","volume":"98","author":"CM Prado","year":"2013","unstructured":"Prado CM, Sawyer MB, Ghosh S et al (2013) Central tenet of cancer cachexia therapy: do patient with advanced cancer have exploitable anabolic potential? Am J Clin Nutr 98:1012\u20131019","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2958_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ejh.12285","volume":"93","author":"V Camus","year":"2014","unstructured":"Camus V, Lanic H, Kraut J et al (2014) Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Eur J Haematol 93(1):9\u201318","journal-title":"Eur J Haematol"},{"issue":"4","key":"2958_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/10428194.2013.816421","volume":"55","author":"H Lanic","year":"2014","unstructured":"Lanic H, Kraut-Tauzia J, Modzelewski R, Clatot F, Mareschal S, Picquenot JM, Stamatoullas A, Lepr\u00eatre S, Tilly H, Jardin F (2014) Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 55(4):817\u2013823","journal-title":"Leuk Lymphoma"},{"key":"2958_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69","journal-title":"Nutr J"},{"key":"2958_CR21","doi-asserted-by":"publisher","unstructured":"Lin GN, Peng JW, Liu PP, Liu DY, Xiao JJ, Chen XQ (2014) Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment. Asia Pac J Clin Oncol. doi: 10.1111\/ajco.12273 . [Epub ahead of print]","DOI":"10.1111\/ajco.12273"},{"issue":"7","key":"2958_CR22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3324\/haematol.11011","volume":"92","author":"CF Skibola","year":"2007","unstructured":"Skibola CF, Curry JD, Nieters A (2007 Jul) Genetic susceptibility to lymphoma. Haematologica 92(7):960\u2013969","journal-title":"Haematologica"},{"issue":"3","key":"2958_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cyto.2012.08.028","volume":"60","author":"B Charbonneau","year":"2012","unstructured":"Charbonneau B, Maurer MJ, Ansell SM et al (2012) Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study. Cytokine 60(3):882\u2013889","journal-title":"Cytokine"},{"issue":"3","key":"2958_CR24","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","volume":"303","author":"A Bonetto","year":"2012","unstructured":"Bonetto A, Aydogdu T, Jin X et al (2012) JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab 303(3):E410\u2013E421","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2958_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/mus.23798","volume":"48","author":"A Bonetto","year":"2013","unstructured":"Bonetto A, Penna F, Aversa Z et al (2013) Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients. Muscle Nerve 48(3):387\u2013392","journal-title":"Muscle Nerve"},{"issue":"2","key":"2958_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.blre.2014.09.010","volume":"29","author":"R Karmali","year":"2015","unstructured":"Karmali R, Dalovisio A, Borgia JA et al (2015) All in the family: clueing into the link between metabolic syndrome and hematologic malignancies. Blood Rev 29(2):71\u201380","journal-title":"Blood Rev"},{"key":"2958_CR27","doi-asserted-by":"publisher","unstructured":"Karmali R, Paganessi LA, Frank RR, Jagan S, Larson ML, Venugopal P, Gregory SA, Christopherson KW 2nd (2013) Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL\/SLL patients. J Leukoc Biol (1):161\u201370","DOI":"10.1189\/jlb.0612301"},{"issue":"6","key":"2958_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3324\/haematol.2010.031567","volume":"96","author":"D Vishwamitra","year":"2011","unstructured":"Vishwamitra D, Shi P, Wilson D et al (2011) Expression and effects of inhibition of type 1 insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma. Heamatolgica 96(6):871\u2013880","journal-title":"Heamatolgica"},{"key":"2958_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12885-016-2424-9","volume":"16","author":"AG Oliveira","year":"2016","unstructured":"Oliveira AG, Gomes-Marcondes MC (2016) Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats. BMC Cancer 16:418. doi: 10.1186\/s12885-016-2424-9","journal-title":"BMC Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2958-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-2958-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2958-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T15:33:02Z","timestamp":1601911982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-2958-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,17]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2958"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-2958-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,17]]}}}